IRVINE, Calif., Jan. 4, 2007 (PRIME NEWSWIRE) -- "While many fear the lack of investment dollars in the stock market by retiring baby boomers, savvy investors are focusing on the areas where this enormous group will soon be spending their money," stated SmallCap Sentinel analyst, D.R. Clark. "Surely, the diminished income of retired boomers will tighten personal spending and investment but it should simultaneously cause a greater consumption of imperative goods and services led most obviously by health care."
"Companies are aggressively growing their health care related business plans with product development and licensing agreements, broadening their revenue-seeking footprint as the boomers head toward their golden years," Clark added.
"Along these lines, IntraOp Medical Corporation (OTCBB:IOPM), announced recently that IntraOp's Mobetron(r) and IOERT will form an integral component in the Chinese government's new initiative to combat lung cancer," Clark added.
Mobetron is a proprietary, mobile electron-beam instrument designed for Intraoperative Electron Radiation Therapy (IOERT), the direct application of radiation to a tumor while a patient is undergoing cancer surgery.
IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer intraoperative radiation therapy safely and effectively - for all cancer patients. The company's flagship product, Mobetron, is the first fully portable, self-shielding intraoperative electron radiation therapy device designed for use in any operating room. Key Mobetron benefits include: increased survival rates, better local tumor control, shorter treatment cycles, and fewer side effects.
The informational report "The Silver Tsunami: Baby Boomers & Biotech Breakthroughs" is available at:
The report will address issues regarding emergent biotechnology potentially affecting companies such as Merck (NYSE:MRK), Varian Medical Systems (NYSE:VAR), and Pfizer Inc. (NYSE:PFE).
Additional information regarding IOPM is available at: http://emergingmarketsllc.com/newsletter.php?url=profiles.php?ID=intraop-medical-corporation-iopm.php
Individuals may also register for future reports at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy, nor offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP was paid $4,500 by Emerging Markets Consulting LLC for this profile and other advertising services over a 45 day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.